Novel synthetic plasmid and Doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice

References

• (CDC) CfDCaP. Selecting the Viruses in the Seasonal Influenza (Flu) Vaccine. Seasonal Influenza (Flu), 2014
   Google Scholar
• (WHO) WHO. Pandemic (H1N1) 2009 briefing note 7. Global Alert and Response (GAR), 2009
   Google Scholar
• Morrow MP, Weiner DB. DNA drugs come of age. Sci Am 2010; 303:48-53; PMID:20583666; http://dx.doi.org/10.1038/scientificamerican0710-48
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat Rev Gen 2008; 9:776-88; PMID:18781156; http://dx.doi.org/10.1038/nrg2432
   PubMed Web of Science ®Google Scholar
• Laddy DJ, Yan J, Corbitt N, Kobasa D, Kobinger GP, Weiner DB. Immunogenicity of novel consensus-based DNA vaccines against avian influenza. Vaccine 2007; 25:2984-9; PMID:17306909; http://dx.doi.org/10.1016/j.vaccine.2007.01.063
   PubMed Web of Science ®Google Scholar
• Yan J, Villarreal DO, Racine T, Chu JS, Walters JN, Morrow MP, Khan AS, Sardesai NY, Kim JJ, Kobinger GP, et al. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. Vaccine 2014; 32:2833-42; PMID:24631084; http://dx.doi.org/10.1016/j.vaccine.2014.02.038
   PubMed Web of Science ®Google Scholar
• Laddy DJ, Yan J, Kutzler M, Kobasa D, Kobinger GP, Khan AS, Greenhouse J, Sardesai NY, Draghia-Akli R, Weiner DB. Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PloS one 2008; 3:e2517; PMID:18575608; http://dx.doi.org/10.1371/journal.pone.0002517
   PubMed Web of Science ®Google Scholar
• Walters AA, Kinnear E, Shattock RJ, McDonald JU, Caproni LJ, Porter N, Tregoning JS. Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines. Gene Ther 2014; 21:645-52; PMID:24830436; http://dx.doi.org/10.1038/gt.2014.37
   PubMed Web of Science ®Google Scholar
• Kendirgi F, Yun NE, Linde NS, Zacks MA, Smith JN, Smith JK, McMicken H, Chen Y, Paessler S. Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1. Hum Vaccin 2008; 4:410-9; PMID:18443425; http://dx.doi.org/10.4161/hv.4.6.6177
   PubMed Web of Science ®Google Scholar
• Pollard C, Rejman J, De Haes W, Verrier B, Van Gulck E, Naessens T, De Smedt S, Bogaert P, Grooten J, Vanham G, et al. Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. Mol Ther 2013; 21:251-9; PMID:23011030; http://dx.doi.org/10.1038/mt.2012.202
   PubMed Web of Science ®Google Scholar
• Desmet CJ, Ishii KJ. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 2012; 12:479-91; PMID:22728526; http://dx.doi.org/10.1038/nri3247
   PubMed Web of Science ®Google Scholar
• Hill V. Production of Closed Linear DNA. WO 2010086626 A1. 2010
   Google Scholar
• Heinrich J, Schultz J, Bosse M, Ziegelin G, Lanka E, Moelling K. Linear closed mini DNA generated by the prokaryotic cleaving-joining enzyme TelN is functional in mammalian cells. J Mol Med 2002; 80:648-54; PMID:12395149; http://dx.doi.org/10.1007/s00109-002-0362-2
   PubMed Web of Science ®Google Scholar
• Thomas PG, Keating R, Hulse-Post DJ, Doherty PC. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006; 12:48-54; PMID:16494717; http://dx.doi.org/10.3201/eid1201.051237
   PubMed Web of Science ®Google Scholar
• Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982; 31:417-27; PMID:6186384; http://dx.doi.org/10.1016/0092-8674(82)90135-0
   PubMed Web of Science ®Google Scholar
• Zanta MA, Belguise-Valladier P, Behr JP. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci U S A 1999; 96:91-6; PMID:9874777; http://dx.doi.org/10.1073/pnas.96.1.91
   PubMed Web of Science ®Google Scholar
• Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg 1972; 70:767-77; PMID:4509641; http://dx.doi.org/10.1017/S0022172400022610
   PubMedGoogle Scholar
• De Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD. Haemagglutination-inbibiting antibody to influenza virus. Dev Biol (Basel), 2003; 115:63-73; PMID:15088777
   PubMedGoogle Scholar
• Bender BS, Croghan T, Zhang L, Small PA, Jr. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 1992; 175:1143-5; PMID:1552285; http://dx.doi.org/10.1084/jem.175.4.1143
   PubMed Web of Science ®Google Scholar
• Hou S, Doherty PC, Zijlstra M, Jaenisch R, Katz JM. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J Immunol 1992; 149:1319-25; PMID:1354233
   PubMed Web of Science ®Google Scholar
• Graham MB, Braciale TJ. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med 1997; 186:2063-8; PMID:9396777; http://dx.doi.org/10.1084/jem.186.12.2063
   PubMed Web of Science ®Google Scholar
• Epstein SL, Lo CY, Misplon JA, Bennink JR. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol 1998; 160:322-7; PMID:9551987
   PubMed Web of Science ®Google Scholar
• Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1998; 221:35-41; PMID:9894896; http://dx.doi.org/10.1016/S0022-1759(98)00170-7
   PubMed Web of Science ®Google Scholar
• Villarreal DO, Wise MC, Walters JN, Reuschel EL, Choi MJ, Obeng-Adjei N, Yan J, Morrow MP, Weiner DB. Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity. Cancer Res 2014; 74:1789-800; PMID:24448242; http://dx.doi.org/10.1158/0008-5472.CAN-13-2729
   PubMed Web of Science ®Google Scholar